PKM and breast carcinoma: For instance, miR-122 in breast cancer-derived exosomes inhibits glucose uptake in recipient cells by downregulating the glycolytic enzymes pyruvate-kinase-2 (PKM2) and GLUT1, inducing nutrient competition in favor of tumor cells and promoting migration [72].